Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 252463, 3 pages

HIV Infection and Cardiovascular Disease

1Postgraduate Studies Program in Cardiology, School of Medicine, Universidade Federal do Rio Grande do Sul, R. Ramiro Barcelos 2600, 90035-003 Porto Alegre, RS, Brazil
2National Institute for Health Technology Assessment (IATS/CNPq), Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos 2350, 90035-003 Porto Alegre, RS, Brazil
3Department of Nutrition, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
4Harvard Medical School, New Research Building, Avenue Louis Pasteur, Room 724, Boston, MA 02115, USA
5Centre for Integrated Health Programs (CIHP), Plot 1129 Kikuyu Close, Off Nariobi Street, Wuse II Abuja, FCT, Nigeria
6ICAP, Mailman School of Public Health Columbia University, 722 West 168th Street, New York, NY 10032, USA
7University of Dakar, Department of Infectious Diseases Fann Hospital, BP 5035, Dakar, Senegal
8HIV/AIDS Department, World Health Organization, 20, Avenue Appia, CH-1211 Geneva 27, Switzerland

Received 20 November 2013; Accepted 20 November 2013

Copyright © 2013 Sandra C. Fuchs et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Fauci and G. K. Folkers, “Toward an AIDS-free generation,” The Journal of the American Medical Association, vol. 308, no. 4, pp. 343–344, 2012. View at Google Scholar
  2. S. G. Deeks, S. R. Lewin, and D. V. Havlir, “The end of AIDS: HIV infection as a chronic disease,” The Lancet, vol. 382, no. 9903, pp. 1525–1533, 2013. View at Google Scholar
  3. P. R. Alencastro, F. H. Wolff, R. R. Oliveira et al., “Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions,” AIDS Research and Therapy, vol. 9, no. 1, p. 29, 2012. View at Google Scholar
  4. J. E. Ho and P. Y. Hsue, “Cardiovascular manifestations of HIV infection,” Heart, vol. 95, no. 14, pp. 1193–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Thienemann, K. Sliwa, and J. K. Rockstroh, “HIV and the heart: the impact of antiretroviral therapy: a global perspective,” European Heart Journal, 2013. View at Publisher · View at Google Scholar
  6. B. Grinsztejn, P. M. Luz, A. G. Pacheco et al., “Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era,” PLoS ONE, vol. 8, no. 4, Article ID e59768, 2013. View at Google Scholar
  7. J. E. Lake and J. S. Currier, “Metabolic disease in HIV infection,” The Lancet Infectious Diseases, vol. 13, no. 11, pp. 964–975, 2013. View at Google Scholar
  8. N. Wada, L. P. Jacobson, M. Cohen, A. French, J. Phair, and A. Muñoz, “Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008,” American Journal of Epidemiology, vol. 177, no. 2, pp. 116–125, 2013. View at Google Scholar
  9. R. B. Effros, C. V. Fletcher, K. Gebo et al., “Workshop on HIV infection and aging: what is known and future research directions,” Clinical Infectious Diseases, vol. 47, no. 4, pp. 542–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Gupta, R. Granich, A. B. Suthar et al., “Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples,” Journal of Acquired Immune Deficiency Syndromes, vol. 62, no. 3, pp. e87–e97, 2013. View at Google Scholar
  11. G. Hirnschall, A. D. Harries, P. J. Easterbrook, M. C. Doherty, and A. Ball, “The next generation of the World Health Organization's global antiretroviral guidance,” Journal of the International AIDS Society, vol. 30, no. 16, Article ID 18757, 2013. View at Google Scholar
  12. M. Doherty, N. Ford, M. Vitoria, G. Weiler, and G. Hirnschall, “The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities,” Current Opinion in HIV and AIDS, vol. 8, no. 6, pp. 528–534, 2013. View at Google Scholar
  13. N. J. Stone, J. Robinson, A. H. Lichtenstein et al., “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Circulation, 2013. View at Publisher · View at Google Scholar
  14. F. D. Fuchs, L. E. Chambless, P. K. Whelton, F. J. Nieto, and G. Heiss, “Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities study,” Hypertension, vol. 37, no. 5, pp. 1242–1250, 2001. View at Google Scholar · View at Scopus
  15. A. A. Steffens, L. B. Moreira, S. C. Fuchs, M. Wiehe, M. Gus, and F. D. Fuchs, “Incidence of hypertension by alcohol consumption: is it modified by race?” Journal of Hypertension, vol. 24, no. 8, pp. 1489–1492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Friis-Møller, R. Thiébaut, P. Reiss et al., “Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs study,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, no. 5, pp. 491–501, 2010. View at Publisher · View at Google Scholar · View at Scopus